Système cardiovasculaire - MedQual

189. Anonymous. Do statins have a role in primary prevention Therapeutics Letter april-june 2003;48.
www.ti.ubc.ca
190. Pignone M. Primary prevention: dyslipidaemia. BMJ Clin Evid [online] 2006 [cited Dec 2007].
www.clinicalevidence.com
191. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering
with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet
2002;360:7-22.
192. Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke
and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk
conditions. Lancet 2004;363:757-767.
193. Johnston SC. Cholesterol lowering with simvastatin reduced stroke in patients with, or at risk for,
vascular disease. Comment on: Heart Protection Study Collaborative Group. Effects of cholesterollowering
with simvastatin on stroke and other major vascular events in 20,536 people with
cerebrovascular disease or other high-risk conditions. ACP Journal Club 2004;141:32.
194. Anonymous. Prendre en charge les accidents vasculaires cérébraux. La Revue Prescrire 2005;262:436-
442.
195. Anonymous. Drugs to prevent vascular events after stroke. Drug Ther Bull 2005;43:53-6.
196. SPARCL investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med
2006;355:549-559.
197. Special Report: The efficacy and safety of statins in the elderly. TEC 2007;21:1-29.
198. Risk estimation and the prevention of cardiovascular disease. SIGN. Feb 2007. www.sign.ac.uk
199. The FIELD study investigators. Effects of long term fenofibrate therapy on cardiovascular events in 9795
people with type 2 diabetes mellitus (the FIELD study): randomised copntrolled trial. Lancet
2005;366:1849-1861.
200. Anonymous. Ezetemibe: a new cholesterol-lowering drug. DTB 2004;42:65-67.
201. Laine C,Goldmann D, Wilson JF. Peripheral Arterial Disease.Ann Intern Med 2007; 146: ITC3-13.
202. ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease [Lower
extremity, renal, mesenteric, and abdominal aortic]: Executive summary. JACC 2006;47:1239-1312.
203. Cassar K. Peripheral arterial disease. BMJ Clin Evid [online] 2007 [cited Dec 2007].
www.clinicalevidence.com
204. Bartelink M, Stoffers H, Boutens E et al. NHG-Standaard Perifeer arterieel vaatlijden Huisarts Wet
2003;46: 848-58. http://nhg.artsennet.nl
205. SIGN. Diagnosis and management of peripheral vascular disease. Draft 1.1/ October 2004.
www.sign.ac.uk
206. Anonymous. Clopidogrel. Geneesmiddelenbulletin 1999;33:8.
207. Anonymous. Aspirine ou clopidogrel en première intention La Revue Prescrire 2002;22:76.
208. Heart Protection Study Group. Randomised trial of the effects of cholesterol-lowering with simvastatin
on peripheral vascular and other major vascular outcomes in 20,536 people with peropheral arterial
disease and other high risk conditions. J Vasc Surg 2007;45:645-654.
209. De Backer T, Vander Stichele R, Bogaert M. Buflomedil for intermittent claudication. Cochrane Database
of Systematic Reviews 2000, Issue 2. Art. No.: CD000988. DOI: 10.1002/14651858.CD000988.
210. Martinez M, Bonfill X, Moreno R et al. Phlebotonics for venous insufficiency. Cochrane Database of
Systematic Reviews 2005, Issue 3. Art. No.: CD003229. DOI: 10.1002/14651858.CD003229.pub2.
211. Pittler M, ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database
Systematic Review 2006, Issue 1. Art. No.: CD003230. DOI: 10.1002/14651858.CD003230.pub3.
212. Simon D, Dix F, McCollum C. Management of venous leg ulcers. BMJ 2004;328:1358-1362.
213. Schweitzer B, Doorenbosch J, Glotzbach R et al. NHG-Standaard Ulcus cruris venosum.
http://nhg.artsennet.nl
214. Jull A, Waters J, Arroll B. Pentoxifylline for treatment of venous leg ulcers: a systematic review. Lancet
2002;359:1550-4.
215. Dale J, Ruckley V, Harper R et al. Randomised, double blind placebo controlled trial of pentoxifylline in
the treatment of venous leg ulcers. BMJ 1999;319:875-8.
216. Van Weert H, Dolan G Wichers Iet al. Oppervlakkige tromboflebitis verhoogt het risico op een diepe
veneuze trombose. Huisarts Wet 20006;49:414-417.
217. Di Nisio M, Middeldorp S, Wichers I. Treatment for superficial trombophlebitis of the leg. Cochrane
Database of Systematic Reviews. 2007, Issue 2. Art. No.: CD004982. DOI:
10.1002/14651858.CD004982.pub3.
40 Système cardiovasculaire